Syndax Pharmaceuticals (SNDX) FCF Margin Growth (1y) (2016 - 2026)
Syndax Pharmaceuticals (SNDX) FCF Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn | 39,720.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39,720.00 |
| Dec 31, 2025 | 64,605.00 |
| Sep 30, 2025 | 34,481.00 |
| Jun 30, 2025 | 181,570.00 |
| Dec 31, 2021 | 419,299.00 |
| Sep 30, 2021 | 462,614.00 |
| Jun 30, 2021 | -69,604.00 |
| Mar 31, 2021 | -175,831.00 |
| Dec 31, 2020 | -76,421.00 |
| Sep 30, 2020 | -257,731.00 |
| Jun 30, 2020 | -234,354.00 |
| Mar 31, 2020 | 23,905.00 |
| Dec 31, 2019 | 61,316.00 |
| Sep 30, 2019 | 262,269.00 |
| Jun 30, 2019 | 69,235.00 |
| Mar 31, 2019 | 84,749.00 |
| Dec 31, 2018 | -289,246.00 |
| Sep 30, 2018 | -153,473.00 |
| Jun 30, 2018 | -12,825.00 |
| Mar 31, 2018 | -113,495.00 |